By Jeffrey Binder
On August 4, the New York Times ran the latest installment in its series on healthcare costs in the U.S. titled "In Need of a New Hip, but Priced Out of the U.S."
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
By Jeffrey Binder
On August 4, the New York Times ran the latest installment in its series on healthcare costs in the U.S. titled "In Need of a New Hip, but Priced Out of the U.S."
By David Pyott
The tide of counterfeit and illegally imported drugs and medical devices continues to be strong, as difficult economic times drives demand for seemingly cheaper alternatives. The sophistication of the counterfeiters and illegal importers makes this an increasingly difficult battle to wage, but the threat these illegally imported drugs pose to consumers is real, making it essential that government agencies, with support from industry, continue efforts to help battle this issue.
By: John Roth
By Caroll Neubauer
It’s that time of year again – the time when sell-side junior analysts say goodbye to primetime television and social lives, the time when buy-side analysts hope that they’ll pass through with no smoking craters in their portfolios, and the time when painfully repetitious hold music starts carving away at the sanity of investors and analysts alike. In short, it’s time for earnings from the med-tech sector.
Kicking off with some of the largest names
Written By Courtney A. Stevens | Staff Attorney, Medmarc Loss Control
On July 9, the FDA issued a new draft guidance document addressing device manufacturers’ responsibility to report adverse events: “Medical Device Reporting for Manufacturers.” The guidance is intended to replace the 1988 and 1997 MDR guidances, and includes several clarifications and additions aimed at providing manufacturers with a clearer and better-defined framework for understanding their reporting obligations.
Stephen Simpson
One of the greatest pleasures I have as FDA commissioner is the opportunity to meet with so many who are making a real difference in the world of health care, including researchers, doctors, drug industry leaders, foundations, and advocates for patients and families, including most recently the Alexandria Summit for Oncology.
by Mike Travis
Now, a flurry of newspaper articles, like this one from the Washington Post, point to a potential reversal in that trend. Motorola, Apple, and Lenovo have all announced plans to open new US factories.
By Sébastien Cuvelier Mussalian
Many of us in the medical sector are looking at the role smartphones could play in healthcare provision. To be honest, discussions over m-health have been going on for years, although with the smartphone era that Apple kick started in 2007, research and development has stepped up a number of gears.